Omass (AgeTech UK) Biomed

High-res Mass Spec drug discovery: G-protein receptor, immuno-dysregulation, protein-protein interactions.

Founded Date: N/A
Headquarters: United Kingdom
Technology: AgeTech Companies
Employee Number: N/A
Industry: UK AgeTech 2020
Number Of Exists: N/A
Funding Status: N/A
Investor Type: N/A
Investment Stage: N/A